Lorazepam and diazepam for relieving catatonic features precipitated by initial hemodialysis in a uremic patient: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 2, 2010, Pages 423-424

  Tsai, Meng Chang ^a   Huang, Tiao Lai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CREATININE; DIAZEPAM; HALOPERIDOL; HEMOGLOBIN; LORAZEPAM; PHOSPHATE; SODIUM; UREA;

ADULT; BODY POSTURE; CASE REPORT; CATATONIA; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DELIRIUM; DISORIENTATION; FATIGUE; HEMODIALYSIS; HUMAN; LETTER; MALE; MUSCLE RIGIDITY; MUTISM; SODIUM BLOOD LEVEL; STUPOR; UREA NITROGEN BLOOD LEVEL; UREMIA; WEAKNESS;

ADULT; CATATONIA; DIAZEPAM; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; RENAL DIALYSIS; UREMIA;

EID: 77649275580     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.12.015     Document Type: Letter

References (15)

1. Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia II: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996, 93:137-143.
2. Carroll B.T., Anfinson T.J., Kennedy J.C., Yendrek R., Boutros M., Bilon A. Catatonic disorder due to general medical conditions. J Neuropsychiatry Clin Neurosci 1994, 6:122-133.
3. Carroll B.T., Goforth H.W., Thomas C., Ahuja N., McDaniel W.W., Kraus M.F., et al. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007, 19:406-412.
4. Carroll B.T., Thomas C., Tugrul K.C., Coconcea C., Goforth H.W. GABA(A) versus GABA(B) in catatonia. J Neuropsychiatry Clin Neurosci 2007, 19:484.
5. Cottencin O., Warembourg F., de Chouly de Lenclave M.B., Lucas B., Vaiva G., Goudemand M., et al. Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1170-1176.
6. Cottencin O., Danel T., Goudemand M., Thomas P., Consoli S.M. Catatonia recognition and treatment. Med Sci Monit 2009, 15:CS129-CS131.
7. Detweiler M.B., Mehra A., Rowell T., Kim K.Y., Bader G. Delirious mania and malignant catatonia: a report of 3 cases and review. Psychiatr Q 2009, 80:23-40.
8. Huang T.L. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005, 59:52-55.
9. Hung Y.Y., Huang T.L. Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol 2006, 29:144-147.
10. Lahutte B., Cornic F., Bonnot O., Consoli A., An-Gourfinkel I., Amoura Z., et al. Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1393-1398.
11. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002, 25:555-577.
12. Northoff G., Eckert J., Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997, 62:404-406.
13. Steinman T.I., Yager H.M. Catatonia in uremia. Ann Intern Med 1978, 89:74-75.
14. Taylor M.A., Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003, 160:1233-1241.
15. Ungvari G.S., Kau L.S., Wai-Kwong T., Shing N.F. The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci 2001, 251(suppl 1):31-34.